BR112014004261B8 - Diagnósticos de vacina melhorada - Google Patents
Diagnósticos de vacina melhoradaInfo
- Publication number
- BR112014004261B8 BR112014004261B8 BR112014004261A BR112014004261A BR112014004261B8 BR 112014004261 B8 BR112014004261 B8 BR 112014004261B8 BR 112014004261 A BR112014004261 A BR 112014004261A BR 112014004261 A BR112014004261 A BR 112014004261A BR 112014004261 B8 BR112014004261 B8 BR 112014004261B8
- Authority
- BR
- Brazil
- Prior art keywords
- bvdv
- improved vaccine
- diarrhea virus
- bovine viral
- viral diarrhea
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 abstract 5
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 241000710778 Pestivirus Species 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526792P | 2011-08-24 | 2011-08-24 | |
| US61/526,792 | 2011-08-24 | ||
| PCT/IB2012/054092 WO2013027149A1 (en) | 2011-08-24 | 2012-08-10 | Improved vaccine diagnostics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014004261A2 BR112014004261A2 (pt) | 2017-03-21 |
| BR112014004261B1 BR112014004261B1 (pt) | 2021-02-02 |
| BR112014004261B8 true BR112014004261B8 (pt) | 2022-11-08 |
Family
ID=46970364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014004261A BR112014004261B8 (pt) | 2011-08-24 | 2012-08-10 | Diagnósticos de vacina melhorada |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9291624B2 (https=) |
| EP (1) | EP2748612B1 (https=) |
| JP (1) | JP6080850B2 (https=) |
| KR (1) | KR101667122B1 (https=) |
| CN (1) | CN103917874B (https=) |
| AR (1) | AR087654A1 (https=) |
| AU (1) | AU2012298229B2 (https=) |
| BR (1) | BR112014004261B8 (https=) |
| CA (1) | CA2846385C (https=) |
| CL (1) | CL2014000434A1 (https=) |
| CY (1) | CY1119873T1 (https=) |
| DK (1) | DK2748612T3 (https=) |
| ES (1) | ES2647764T3 (https=) |
| HR (1) | HRP20171623T1 (https=) |
| HU (1) | HUE034632T2 (https=) |
| LT (1) | LT2748612T (https=) |
| ME (1) | ME02909B (https=) |
| MX (1) | MX351704B (https=) |
| NO (1) | NO2746715T3 (https=) |
| PL (1) | PL2748612T3 (https=) |
| PT (1) | PT2748612T (https=) |
| RS (1) | RS56579B1 (https=) |
| SI (1) | SI2748612T1 (https=) |
| UY (1) | UY34286A (https=) |
| WO (1) | WO2013027149A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201113942D0 (en) * | 2011-08-12 | 2011-09-28 | Nec Corp | Communication system |
| BR112014004261B8 (pt) | 2011-08-24 | 2022-11-08 | Zoetis Llc | Diagnósticos de vacina melhorada |
| CN103197082B (zh) * | 2013-04-16 | 2015-07-15 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 牛病毒性腹泻病毒抗体快速检测试纸条 |
| RU2689143C1 (ru) * | 2013-12-19 | 2019-05-24 | Интервет Интернэшнл Б.В. | Усовершенствованный диагностический тест для csfv антител |
| CN108430504A (zh) * | 2015-12-30 | 2018-08-21 | 英特维特国际股份有限公司 | 瘟病毒标记疫苗 |
| CN109136267B (zh) * | 2018-09-19 | 2023-03-31 | 天康生物股份有限公司 | BVDV Erns蛋白和抗体及筛选BVDV感染的牛的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
| US6174667B1 (en) | 1997-09-23 | 2001-01-16 | Cornell Research Foundation, Inc. | Bovine viral diarrhea virus serum antigen capture |
| EP0924298A1 (en) * | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Protein expression in baculovirus vector expression systems |
| CA2297694C (en) | 1999-02-12 | 2008-04-22 | Akzo Nobel N.V. | Antibodies and diagnostic methods for the diagnosis of pestviruses |
| EP1170367A1 (en) * | 2000-06-27 | 2002-01-09 | Bayer Ag | BVDV virus-like particles |
| CN1460857A (zh) * | 2003-06-10 | 2003-12-10 | 陈睿锋 | 牛病毒性腹泻病毒抗体间接elisa检测方法 |
| US7763460B2 (en) * | 2005-06-24 | 2010-07-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting herpes simplex virus type 2 |
| WO2010064164A1 (en) | 2008-12-03 | 2010-06-10 | Pfizer Inc. | Bovine viral diarrhea virus with a modified erns protein |
| CN102023217A (zh) * | 2010-12-01 | 2011-04-20 | 扬州大学 | 牛病毒性腹泻病毒双抗夹心生物素-亲和素elisa检测试剂盒及使用方法 |
| BR112014004261B8 (pt) | 2011-08-24 | 2022-11-08 | Zoetis Llc | Diagnósticos de vacina melhorada |
-
2012
- 2012-08-10 BR BR112014004261A patent/BR112014004261B8/pt active IP Right Grant
- 2012-08-10 SI SI201231121T patent/SI2748612T1/sl unknown
- 2012-08-10 RS RS20171180A patent/RS56579B1/sr unknown
- 2012-08-10 US US14/239,917 patent/US9291624B2/en active Active
- 2012-08-10 PL PL12768901T patent/PL2748612T3/pl unknown
- 2012-08-10 HR HRP20171623TT patent/HRP20171623T1/hr unknown
- 2012-08-10 EP EP12768901.6A patent/EP2748612B1/en active Active
- 2012-08-10 CN CN201280052231.6A patent/CN103917874B/zh active Active
- 2012-08-10 ES ES12768901.6T patent/ES2647764T3/es active Active
- 2012-08-10 CA CA2846385A patent/CA2846385C/en active Active
- 2012-08-10 JP JP2014526574A patent/JP6080850B2/ja active Active
- 2012-08-10 PT PT127689016T patent/PT2748612T/pt unknown
- 2012-08-10 DK DK12768901.6T patent/DK2748612T3/da active
- 2012-08-10 AU AU2012298229A patent/AU2012298229B2/en active Active
- 2012-08-10 KR KR1020147007225A patent/KR101667122B1/ko active Active
- 2012-08-10 LT LTEP12768901.6T patent/LT2748612T/lt unknown
- 2012-08-10 ME MEP-2017-251A patent/ME02909B/me unknown
- 2012-08-10 HU HUE12768901A patent/HUE034632T2/en unknown
- 2012-08-10 WO PCT/IB2012/054092 patent/WO2013027149A1/en not_active Ceased
- 2012-08-10 MX MX2014002170A patent/MX351704B/es active IP Right Grant
- 2012-08-23 AR ARP120103114A patent/AR087654A1/es active IP Right Grant
- 2012-08-23 UY UY0001034286A patent/UY34286A/es active IP Right Grant
-
2013
- 2013-12-04 NO NO13005636A patent/NO2746715T3/no unknown
-
2014
- 2014-02-24 CL CL2014000434A patent/CL2014000434A1/es unknown
-
2017
- 2017-11-27 CY CY20171101242T patent/CY1119873T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014004261B8 (pt) | Diagnósticos de vacina melhorada | |
| BR112017008165B8 (pt) | anticorpo de domínio único direcionado contra um componente intracelular e seu uso, métodos in vitro para medir os níveis do referido anticorpo e para diagnosticar um distúrbio mediado por um componente intracelular, polipeptídeo isolado e composição compreendendo o referido anticorpo ou polipeptídeo isolado | |
| PE20251851A1 (es) | Terapia basada en anticuerpos de amiloidosis por transtiretina (ttr) y anticuerpos derivados de humanos de la misma | |
| CL2018000378A1 (es) | Receptores de antígenos quiméricos basados en anticuerpos de dominio simple y métodos de uso de estos | |
| BR112016014010A2 (pt) | métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador | |
| BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
| MX2017012802A (es) | Anticuerpos antisortilina y métodos para su uso. | |
| BR112014008382A2 (pt) | anticorpo especificamente ligando a epítope no domínio sema do c-met | |
| EP3587439A3 (en) | Improved quantification of vaccine compositions | |
| BR112016019057A2 (pt) | método de induzir uma resposta imune contra uma doença em um indivíduo | |
| BR112013008407A2 (pt) | antígenos de clostridium difficile | |
| BR112016016737A2 (pt) | Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma | |
| MX391037B (es) | Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos. | |
| BR112016009460A8 (pt) | método para detectar a presença de anticorpos neutralizantes, e, kit | |
| EA201991843A1 (ru) | Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов | |
| MX2017005524A (es) | Metodos y composiciones para el virus del dengue recombinante para el desarrollo de vacunas y de diagnostico. | |
| EA201992317A1 (ru) | Композиции и способы для диагностики рака легких | |
| BR112016023915A2 (pt) | métodos de permissão de reação imunológica, de imunização de mamíferos e de tratamento ou prevenção de infecções, composições, peptídeo isolado, anticorpo, ácido nucleico isolado, construção genética e célula hospedeira | |
| BR112013027851A2 (pt) | métodos para identificar um indivíduo caucasiano e para determinar uma suscetibilidade do indivíduo caucasiano de ter ou desenvolver a degeneração macular relacionada com a idade, e, kit | |
| BR112017020606A2 (pt) | ?composições e métodos de uso de peptídeos de interleucina-10 e anticorpos anti-interleucina? | |
| AR102966A1 (es) | ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO M DEL VIRUS METAPNEUMOVIRUS HUMANO (hMPV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR hMPV | |
| GB2541596A (en) | Method and composition for determining specific antibody responses to species of filovirus | |
| EA201401101A1 (ru) | Способ лабораторной диагностики пневмонии | |
| WO2013049822A3 (en) | Diagnostic method for determining animals persistently infected (pi) with bovine viral diarrhea virus (bvdv) | |
| BR112017006472A2 (pt) | kit para medir título de uma proteína compreendendo fc humano usando elisa indireto e método para medir o título de uma proteína compreendendo fc humano usando o mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/08/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: ZOETIS SERVICES LLC (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: ZOETIS SERVICES LLC (US) |